Skip to main content

Peer Review reports

From: Astragaloside IV restrains pyroptosis and fibrotic development of pulmonary artery smooth muscle cells to ameliorate pulmonary artery hypertension through the PHD2/HIF1α signaling pathway

Original Submission
31 Oct 2022 Submitted Original manuscript
19 Jan 2023 Reviewed Reviewer Report
18 Feb 2023 Reviewed Reviewer Report
17 Apr 2023 Author responded Author comments - Yan Ma
Resubmission - Version 2
17 Apr 2023 Submitted Manuscript version 2
18 May 2023 Author responded Author comments - Yan Ma
Resubmission - Version 3
18 May 2023 Submitted Manuscript version 3
6 Jun 2023 Author responded Author comments - Yan Ma
Resubmission - Version 4
6 Jun 2023 Submitted Manuscript version 4
18 Jun 2023 Reviewed Reviewer Report
3 Jul 2023 Reviewed Reviewer Report
28 Jul 2023 Author responded Author comments - Yan Ma
Resubmission - Version 5
28 Jul 2023 Submitted Manuscript version 5
30 Jul 2023 Author responded Author comments - Yan Ma
Resubmission - Version 6
30 Jul 2023 Submitted Manuscript version 6
3 Aug 2023 Reviewed Reviewer Report
9 Aug 2023 Reviewed Reviewer Report
29 Aug 2023 Author responded Author comments - Yan Ma
Resubmission - Version 7
29 Aug 2023 Submitted Manuscript version 7
7 Sep 2023 Reviewed Reviewer Report
Resubmission - Version 8
Submitted Manuscript version 8
Publishing
15 Sep 2023 Editorially accepted
12 Oct 2023 Article published 10.1186/s12890-023-02660-9

You can find further information about peer review here.

Back to article page